Cargando…
Isolated positive deamidated gliadin peptide‐IgG has limited diagnostic utility in coeliac disease
AIM: Deamidated gliadin peptide‐IgG (DGP‐IgG) antibody serology testing is widely utilised in screening for coeliac disease in Australia; however, it is used sparingly in Europe. The aim of this study was to assess the diagnostic value of a positive DGP‐IgG in the setting of a negative tissue transg...
Autores principales: | Vootukuru, Nikil, Singh, Harveen, Giles, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545789/ https://www.ncbi.nlm.nih.gov/pubmed/35726522 http://dx.doi.org/10.1111/jpc.16071 |
Ejemplares similares
-
Coeliac disease detection with an IgA/IgG-deamidated gliadin peptide based point of care test in community pharmacies
por: Lau, Michelle S., et al.
Publicado: (2019) -
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first!
por: Arigliani, Michele, et al.
Publicado: (2017) -
‘Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model’
por: Lau, Michelle Shui Yee, et al.
Publicado: (2016) -
Erratum to: ‘Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model’
por: Lau, Michelle Shui Yee, et al.
Publicado: (2016) -
Allergenicity of Deamidated and/or Peptide-Bond-Hydrolyzed Wheat Gliadin by Transdermal Administration
por: Abe, Ryosuke, et al.
Publicado: (2020)